DEBRISOQUINE HYDROXYLATION CAPACITY - PROBLEMS OF ASSESSMENT IN 2 POPULATIONS

被引：44

作者：

INABA, T ^{[1
]}

OTTON, SV ^{[1
]}

KALOW, W ^{[1
]}

机构：

[1] UNIV TORONTO, FAC MED, DEPT PHARMACOL, TORONTO M5S 1A8, ONTARIO, CANADA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1981年 / 29卷 / 02期

关键词：

D O I：

10.1038/clpt.1981.35

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：218 / 223

页数：6

共 17 条

[1]

ABRAMS WB, 1969, CLIN PHARMACOL THER, V10, P702

[2] INDIVIDUAL-DIFFERENCES IN DISPOSITION OF DRUGS METABOLIZED IN BODY [J].

ALVAN, G .

CLINICAL PHARMACOKINETICS, 1978, 3 (02) :155-175

[3] UPTAKE OF DEBRISOQUIN AND GUANETHIDINE BY HUMAN BLOOD PLATELETS [J].

BOULLIN, DJ ;

OBRIEN, RA .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1968, 20 (05) :403-&

[4] DEFECTIVE N-OXIDATION OF SPARTEINE IN MAN - NEW PHARMACOGENETIC DEFECT [J].

EICHELBAUM, M ;

SPANNBRUCKER, N ;

STEINCKE, B ;

DENGLER, HJ .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) :183-187

[5] A FAMILY AND POPULATION STUDY OF THE GENETIC-POLYMORPHISM OF DEBRISOQUINE OXIDATION IN A WHITE BRITISH-POPULATION [J].

EVANS, DAP ;

MAHGOUB, A ;

SLOAN, TP ;

IDLE, JR ;

SMITH, RL .

JOURNAL OF MEDICAL GENETICS, 1980, 17 (02) :102-105

[6] DEFICIENT METABOLISM OF DEBRISOQUINE AND SPARTEINE [J].

INABA, T ;

OTTON, SV ;

KALOW, W .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (04) :547-549

[7]

KALOW W, 1979, CLIN PHARMACOL THER, V26, P766

[8] ETHNIC DIFFERENCE IN DRUG-METABOLISM - DEBRISOQUINE 4-HYDROXYLATION IN CAUCASIANS AND ORIENTALS [J].

KALOW, W ;

OTTON, SV ;

KADAR, D ;

ENDRENYI, L ;

INABA, T .

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1980, 58 (09) :1142-1144

[9] BIOCHEMICAL AND GENETIC FACTORS REGULATING DILANTIN METABOLISM IN MAN [J].

KUTT, H .

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1971, 179 (JUL6) :704-&

[10] POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MAN [J].

MAHGOUB, A ;

IDLE, JR ;

DRING, LG ;

LANCASTER, R ;

SMITH, RL .

LANCET, 1977, 2 (8038) :584-586

← 1 2 →